[1]李瑞瑞 李学斌.起搏诱导性心肌病临床研究进展[J].心血管病学进展,2022,(2):133.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.010]
　LI RuiruiLI Xuebin.Progress of Clinical Research on Pacing-Induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(2):133.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.010]
点击复制

起搏诱导性心肌病临床研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年2期
页码:
133
栏目:
综述
出版日期:
2022-02-25

文章信息/Info

Title:
Progress of Clinical Research on Pacing-Induced Cardiomyopathy
作者:
李瑞瑞1; 2 李学斌1
(1.北京大学人民医院心内科,北京 100032;2.河北省沧州市人民医院,河北 沧州 061000)
Author(s):
LI Ruirui1; 2LI Xuebin
(1.Department of CardiologyPeking University Peoples Hospital,Beijing 100032,China2.Department of CardiologyCangzhou Peoples HospitalCangzhou 061000HebeiChina)
关键词:
起搏诱导性心肌病; 左室射血分数; 心脏再同步化治疗
Keywords:
Pacinginduced cardiomyopathy; Left ventricle ejection fraction; Cardiac resynchronization therapy
DOI:
10.16806/j.cnki.issn.1004-3934.2022.02.010
摘要:
起搏诱导性心肌病通常定义为长期右心室起搏出现左室射血分数的下降。然而最近的研究数据表明，仅依据左室射血分数下降来定义起搏诱导性心肌病可能低估了长期右心室起搏有害影响的发生率，当出现起搏诱导性心肌病时，主要的治疗方式为升级成心脏再同步化治疗，而最新的数据表明，传导系统起搏可能在预防和治疗起搏诱导性心肌病的有一定优势。现就起搏诱导性心肌病的研究进展做一综述。
Abstract:
Pacinginduced cardiomyopathy (PICM) is most commonly defined as a drop in left ventricle ejection fraction in the setting of chronic,high burden right ventricle pacing. However,recent data suggest that defining PICM solely on the basis of reduced left ventricular ejection fraction may underestimate the incidence of long-term harmful effects of right ventricular pacing. When PICM occurs,the primary treatment is upgrading to cardiac resynchronization therapy,and the latest data suggest that conduction system pacing may have some advantages in the prevention and treatment of pacemaker-induced cardiomyopathy.??This article reviews the research progress of PICM

参考文献/References:

[1].Merchant FMMittal S.Pacing induced cardiomyopathy[J]. J Cardiovasc Electrophysiol,2020,31(1):286-292.
[2].Yu CM,Fang F,Luo XX,et al. Long-term follow-up results of the Pacing to Avoid Cardiac Enlargement (PACE) trial[J]. Eur J Heart Fail,2014,16(9):1016-1025.
[3].Sweeney MO,Hellkamp AS,Ellenbogen KA,et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction[J]. Circulation,2003,107(23):2932-2937.
[4].Steinberg JS, Fischer A, Wang P,et al.The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial Ⅱ[J]. J Cardiovasc Electrophysiol2005,16(4):359-365.
[5].Curtis AB,Worley SJ,Adamson PB,et al. Biventricular pacing for atrioventricular block and systolic dysfunction[J]. N Engl J Med,2013,368(17):1585-1593.
[6].Glikson,M,Nielsen JC,Kronborg MB,et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy[J]. Eur Heart J,2021,42(35):3427-3520.
[7].Nielsen JC,Kristensen L,Andersen HR,et al. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome[J]. J Am Coll Cardiol,2003,42(4):614-623.
[8].林丛等起搏诱导性心肌病的临床特征和危险因素分析. 心电与循环2021,40(1):45-48.
[9].林大卫,王耀晟. 起搏器植入所致心房颤动机制的研究进展[J]. 实用医学杂志,2020,36(7):979-982.
[10].Khurshid S,Obeng-Gyimah E,Supple GE,et al. Reversal of pacing-induced Cardiomyopathy following cardiac resynchronization therapy[J]. JACC Clin Electrophysiol,2018,4(2):168-177.
[11].蔡迟,华伟,牛红霞,等. 真实世界中常规起搏器升级为心脏再同步治疗的疗效分析[J]. 中华心律失常学杂志,2021,25(2):117-121.
[12].Cheung JW,Ip JE,Markowitz SM,et al. Trends and outcomes of cardiac resynchronization therapy upgrade procedures:a comparative analysis using a United States National Database 2003–2013[J]. Heart Rhythm,2017,14(7):1043-1050.
[13]. Deshmukh P,Casavant DA,Romanyshyn M,et al. Permanent,direct His-bundle pacing:a novel approach to cardiac pacing in patients with normal His-Purkinje activation[J]. Circulation,2000,101(8):869-877.
[14].Huang W,Su L,Wu S,et al. A novel pacing strategy with low and stable output:pacing the left bundle branch immediately beyond the conduction block[J]. Can J Cardiol,2017,33(12):1736.e1-1736.e3.

相似文献/References:

[1]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
　YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(2):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[2]喻瑜 华伟.希氏-浦肯野系统起搏用于治疗起搏诱导性心肌病的临床研究进展[J].心血管病学进展,2022,(6):481.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.001]
　YU Yu,HUA Wei.Clinical Research Progress of His-Purkinje System Pacing in the Treatment of Pacing-Induced Cardiomyopathy[J].Advances in Cardiovascular Diseases,2022,(2):481.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.001]
[3]何佳玲 陈应忠 刘浩然 叶滔 谢轲 徐俊波 刘汉雄 蔡琳.预防性静脉-动脉体外膜肺氧合支持下的经导管主动脉瓣植入术[J].心血管病学进展,2022,(2):113.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.005]
　HE JialingCHEN YingzhongLIU HaoranYE TaoXIE KeXU Junbo,LIU HanxiongCAI Lin.Prophylactic Venous-Arterial Extracorporeal Membrane Oxygenation Supported Transcatheter Aortic Valve Implantation[J].Advances in Cardiovascular Diseases,2022,(2):113.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.005]
[4]马浩 张世成 宋仰午 黄思源 赵栋 凤玮.单纯冠状动脉旁路移植术治疗左心室室壁瘤的回顾性队列研究[J].心血管病学进展,2023,(5):465.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.019]
　MA Hao,ZHANG Shicheng,SONG Yangwu,et al.Surgical Effects of Coronary Artery Bypass Grafting Alone for Patients with Left Ventricular Aneurysm:A Retrospective Cohort Study[J].Advances in Cardiovascular Diseases,2023,(2):465.[doi:10.16806/j.cnki.issn.1004-3934.2023.05.019]

更新日期/Last Update: 2022-08-19